December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Focal ERG Monitoring of Transpupillary Thermotherapy: Potential Use for Optimizing Subthreshold Laser Treatment of Choroidal Neovascularization
Author Affiliations & Notes
  • B Falsini
    Ophthalmology Catholic University Rome Italy
  • F Focosi
    Ophthalmology Catholic University Rome Italy
  • M Piccardi
    Ophthalmology Catholic University Rome Italy
  • E Pirozzi
    Ophthalmology Catholic University Rome Italy
  • F Coccimiglio
    Ophthalmology Catholic University Rome Italy
  • F Molle
    Ophthalmology Catholic University Rome Italy
  • C Manganelli
    Ophthalmology Catholic University Rome Italy
  • MA Mainster
    Ophthalmology University of Kansas Medical Center Kansas City MO
  • Footnotes
    Commercial Relationships    B. Falsini, Iris Medical P; F. Focosi, None; M. Piccardi, None; E. Pirozzi, None; F. Coccimiglio, None; F. Molle, None; C. Manganelli, None; M.A. Mainster, Iris Medical C. Grant Identification: Support: Iris Medical
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4409. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B Falsini, F Focosi, M Piccardi, E Pirozzi, F Coccimiglio, F Molle, C Manganelli, MA Mainster; Focal ERG Monitoring of Transpupillary Thermotherapy: Potential Use for Optimizing Subthreshold Laser Treatment of Choroidal Neovascularization . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4409.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the potential use of focal electroretinography for monitoring and optimizing transpupillary thermotherapy (TTT) for occult choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Methods: We evaluated 24 eyes of 24 patients undergoing TTT for occult CNV due to AMD. TTT was performed according to the Reichel et al. protocol (1999). A 630-nm photocoagulator aiming beam was modified for use as a 41-Hz square-wave focal electroretinogram (FERG) stimulus. It was presented on a light-adapting background, using a Goldmann-type lens (visual angle, 18°; mean luminance, 100 cd/m2). FERGs were continuously monitored before, during and after TTT. The amplitude and phase of the FERG's fundamental harmonic were measured. TTT outcomes were evaluated one and three months after treatment by visual acuity testing, ophthalmoscopy and fluorescein angiography (FA). Results: Stabilization or improvement of visual acuity occurred in 23 of 24 eyes treated with TTT. A reduction in exudation was observed in the FAs of 14 of the 24 eyes. There were no suprathreshold or adverse clinical events. Mean FERG amplitudes decreased transiently during TTT (-16.4% ± 6.6, p < 0.05), returning to pre-TTT values within 60-sec after treatment ended. TTT did not alter FERG phase. Post-TTT changes in visual acuity (i.e., the ratio of post- to pre-TTT visual acuity) were positively correlated (r = 0.55, p = 0.02) with FERG amplitude changes (i.e., the percentage change from the pre-TTT value) during TTT. The best angiographic outcomes were associated with the smallest decreases in FERG amplitude during TTT (p = 0.01). Conclusion: In patients undergoing TTT for occult CNV in AMD, improved visual and angiographic outcomes are correlated with lower reductions in intraoperative FERG amplitudes, suggesting the potential use of focal electroretinography for monitoring and modulating laser parameters for individual eyes and macular lesions.

Keywords: 308 age-related macular degeneration • 454 laser • 395 electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×